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As two natural oligosaccharide esters, 3,6’-Disinapoyl sucrose (DISS) and tenuifolisideA
(TFSA) are originating from the root of Polygala tenuifolia Willd, a traditional Chinese
medicine used in treatment of mental disorders. Previous reports have shown that
both of them possess in vitro neuroprotective effects by stimulating different upstream
pathways related with cyclic AMP-responsive element-binding protein (CREB). In
the present study, we investigated the additive neuroprotective effects of DISS and
TFSA on Glu-induced damage of SY5Y cells and purposed the possible underlying
mechanism. The interaction between DISS and TFSA showed a clear-cut synergistic
effect as evidenced by combination index (CI). Additional evidence from biochemical
(NOS activity) assays confirmed their additive inhibition on the Glu-induced NOS
hyperactivation. Moreover, we showed that co-treatment of DISS and TFSA resulted in
an additively up-regulated phosphorylation of CREB as well as increased expressions of
CRTC1 and BDNF. Neuroprotective effects of DISS and TFSA on Glu-induced decrease
in cell viability were blocked by MAPK/ERK1/2 inhibitor (U0126) and PI3-K inhibitor
(LY290042). Nevertheless, the CRTC1 or BDNF expression induced by these two
compounds was significantly reduced in the presence of either ERK or PI3-K inhibitor,
indicating that the two oligosaccharide esters shared some common pathways in the
regulation of CREB-BDNF pathway. Taken together, we, for the first time, showed that
DISS and TFSA exerted the additive neuroprotective effects on CREB-BDNF signaling
pathway through complementary mechanisms.
Keywords: DISS, TFSA, CREB, synergistic effect, neuroprotective effect
INTRODUCTION
As a common mental disorder, depression is estimated to affect 350 million people in the world by
2030 (Mathers et al., 2008). Conventional medicines for many depressed patients address only low
efficacy but with untoward side effects (Blumenthal et al., 2012). Chinese herbs have a very long
history for the use in the treatment of depression with few side effects reported. Extract of Radix
Polygalae (the root of Polygala tenuifolia Willd) has been used as an antidepressant, a tranquilizer
and an antipsychotic agent in the past several years (Chang and But, 1986; Hu et al., 2009; Liu
et al., 2010). 3,6’-Disinapoyl sucrose (DISS) and tenuifoliside A (TFSA) are the principle active
ingredients in the extract of Radix Polygalae. Our previous studies have indicated that both of
DISS and TFSA have neuroprotective effects in different in vitro models (Hu et al., 2010, 2011,
2012). In addition, both can stimulate the expression and phosphorylation of key proteins in the
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cAMP response element-binding protein (CREB) signaling
pathway (Liu et al., 2010; Dong et al., 2014).
cAMP response element-binding protein with its upstream
and downstream effectors is thought to play a role in
the pathophysiology of depression as well as in efficacy of
antidepressant treatment (Majumder et al., 2004; Nair and
Vaidya, 2006; Sakamoto et al., 2011). A serial of activity-
inducible kinases (such as protein kinase C, Ca2+/CaM-
dependent kinases II and IV, protein kinase A, ribosomal
S6 kinase, AKT, mitogen/stress-activated kinase, and MAPK
kinase 2) can increase the phosphorylation of CREB (Ghosh
et al., 1994; Ginty et al., 1994; Tan et al., 1996; Hardingham
et al., 1999; Li et al., 2011). Meanwhile, CREB-regulated
transcription co-activators (CRTCs) can also dramatically
increase CREB-mediated transcriptional activity independently
of the phosphorylation status of CREB (Reichardt, 2006). Both
of the above-mentioned mechanisms upregulate the downstream
neurotrophic factor (BDNF) and affect neuronal proliferation,
synaptic function, and synaptic plasticity.
Synergy may occur when two or more herbal ingredients are
combined, which can mutually enhance each other’s effect when
compared with administration alone (Ma et al., 2009). Therefore,
we combined DISS and TFSA to determine if such a combination
produced an additive or synergistic neuroprotective effect.
In the present study, we specifically aimed to assess the
combination effect of two compounds, DISS and TSFA, in
mediating neuroprotective effects in vitro and to further
explore their additive mechanism via CREB pathway [CRTC1,
pCREB (phosphor-CREB), BDNF]. Our goal was to investigate
the potential usefulness of combining candidate active
oligosaccharide esters for the treatment of mental disorders, by
which we could reduce the risk of adverse effects by lowering
their concentrations.
MATERIALS AND METHODS
Materials
3,6’-Disinapoyl sucrose and TSFA were isolated from Radix
Polygalae, identified by a combination of spectral methods (UV,
IR, MS, and NMR) and purified by HPLC (purity >90%).
U0126 and LY294002 were purchased from Selleck Chemicals
LLC (Houston, TX, USA). Dulbecco’s modified Eagle’s medium
(nutrient mixture F-12; DMEM/F-12) was obtained from Gibco
(Carlsbad, CA, USA). Fetal bovine serum (FBS) was supplied
by Hyclone (Logan, UT, USA). Polyclonal rabbit antibodies
against BDNF, CREB, pCREB, CRTC1, and β-actin were all
provided by Bioworld Technology (Atlanta, GA, USA) or Abcam
(Burlingame, CA, USA).
Cell Culture
SH-SY5Y human neuroblastoma cells were obtained from
the American Type Culture Collection (Rockville, MD, USA)
and cultured in DMEM/F-12 supplemented with 10% heat-
inactivated FBS and 1% penicillin-steptomycin (50 U/mL). The
cells were maintained in a humidified atmosphere with 5% CO2
at 37◦C. The culture medium was refreshed every other day.
Cell Viability Assay and Synergy
Experiments
Cells were seeded into 96-well plates at a density of approximately
2 × 103 cells/well and then grown for 24 h. Subsequently,
cells were cultured with serum-free medium (0.1% BSA in
growth medium without FBS) for another 24 h and then
treated with DISS or TFSA at desired concentrations (15.625–
2,000 µM). After 48-h treatment, cell viability was determined
by Cell Counting Kit-8 (CCK-8; Keygen Biotech., Nanjing,
China). Results were from six independent experiments, and each
experiment was run in triplicate. The data were presented as
percentage relative to untreated cells. The drug response curve
was generated based on the determined relative cell viability, and
50% effective concentration (EC50) was measured using software
Graphpad Prism5 (Roscilli et al., 2016). EC50 of combination was
tested on TFSA at a fixed concentration (40 µM) plus DISS at
various concentrations (600, 300, 150, 75, 37.5, 18.75 µmol/L).
Combination effects of DISS and TFSA treatment were evaluated
by calculating the combination index (CI) value as previously
reported by Chou (Chou, 2006). CI = EC50(DISS plus TFSA)/EC50
(DISS alone) + CTFSA/EC50 (TFSA alone). CTFSA was the TFSA
concentration used in combination. In this analysis, synergism
was defined as follows: CI > 1.1, antagonism; 1.1 < CI < 0.9,
additive effect; 0.9 < CI < 0.3, synergic effect; and CI < 0.3,
strong synergism.
Inhibition Experiments
Briefly, cells were seeded into a 96-well plate or 6-well plate at a
density of approximately 3 × 103 cells/well or 1 × 104 cells/well
with full growth medium. After 24 h, medium was refreshed by
serum-free medium and incubated 24 h. Cells were exposed to
8 mM glutamate (Glu) for 24 h, followed by treatment with DISS
(75/150 µM), TFSA (25/50 µM) alone or combinations of DISS
and TFSA at desired concentrations with or without antagonists
(U0126/LY294002) for 24 or 48 h (assay BNDF mRNA, western
blot), and each concentration of the inhibitor was established
according to a previous study with minor modifications (Hu
et al., 2014).
Measurement of NOS and iNOS Activities
Cells were seeded into 6-well plates at a density of approximately
1 × 104 cells/well cells and grown for 24 h. Subsequently, cells
were exposed to 8 mM Glu for another 24 h. After different
treatments for 48 h, cells were collected and re-suspended in
PBS. Cell suspension was centrifuged, and the supernatant was
collected into EP tubes and then stored at low temperature (0◦C).
NOS and iNOS activities as well as NO content were determined
using a reagent kit (Nanjing Jiancheng Bioengineering Institute,
Nanjing, China) using an ultraviolet spectrophotometer at a
wavelength of 540 nm.
BDNF Expression at the mRNA Level
Total RNA was extracted from cells using Trizol reagent.
RNA concentration was determined using an Eppendorf
BioPhotometer plus (Eppendorf, Germany). Subsequently,
purified RNA was reversely transcribed into cDNA using iScript
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cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA) according to
the manufacture’s instructions. BDNF expression at the mRNA
level was assessed by qPCR using SsO Fast Eva Green Supermix
(Bio-Rad, Hercules, CA, USA) according to the manufacturer’s
instructions. GAPDH was selected as the housekeeping gene.
The following sequences were used in the study:
BDNF up Primer: GACGGTCACAGTCCTAGAGAA,
BDNF low primer CCTTATGAATCGCCAGCCAAT;
GAPDH up primer ACTTCAACAGAGACACCCACTC,
GAPDH low primer TCTCTCTTCCTCTTGTGCTCTTGC.
Briefly, after an initial denaturation step at 95◦C for 30 sec,
amplifications were carried out with 40 cycle at a melting
temperature of 95◦C for 5 sec, an annealing temperature of
60◦C for 5 sec, and an extension temperature of 65◦C for 5 sec.
Standard curves were generated for each gene, and the gene
expression at the mRNA level was calculated relative to serial
dilution of cDNA as described in Bio-Rad iQ5 System (California,
USA). All experiments were conducted in triplicates. Relative
expression was estimated using the 2−11Ct method.
Western Blotting
After 48-h treatment, cells were collected and washed twice
with ice-cold PBS. Subsequently, cell pellet was lyzed in lysis
buffer (1% Triton, 20 mM Tris–HCl, 150 mM NaCl, 1 mM
EDTA, pH 7.5) supplemented with one tablet of complete
protease inhibitor cocktail (Roche, Laval, QC, Canada) and
phosphatase inhibitor cocktail (Sigma, St. Louis, MO, USA), and
the cell lysates were centrifuged at 1,000 g for 10 min at 4◦C.
Total amounts of proteins in each sample were determined by
BCA kit, and the protein concentrations of all samples were
adjusted to be the same. Supernatants containing 20 µg proteins
were separated on 10% SDS-PAGE and electrotransferred
onto polyvinylidenedifluoride (PVDF) membranes. Blots were
FIGURE 1 | EC50 of combination of DISS (3,6’-Disinapoyl sucrose) and TFSA (tenuifolisideA). Cells were treated with DISS or TFSA at desired
concentrations (15.625–2,000 µM) then cell viability were determined by cell counting kit-8. DISS or TFSA response curve was generated based on the determined
relative cell viability, EC50 was measured. EC50 of combination was tested on TFSA at a fixed concentration (40 µM) plus DISS at various concentrations (600, 300,
150, 75, 37.5, 18.75 µmol/L). The EC50 of DISS, TFSA and the combination of DISS and TFSA was 606.4 ± 23.3 µM, 237.8 ± 13.3 µM, and 83.86 ± 1.06 µM,
respectively. CI value of combination was 0.31 (CI < 1 means synergic effect).
FIGURE 2 | Combination effect of DISS and TFSA on cell viability in SY5Y cells (n = 18). SY5Y cells were exposed to 8 mM Glu for 24 h, followed by
combination treatment of DISS and TFSA as well as inhibitors (U0126, LY294002). (A) Cells were treated by DISS and inhibitors. (B) Cells were treated by TFSA and
inhibitors. (C) Cells were treated by combination of DISS, TFSA and inhibitors. ∗p < 0.05 and ∗∗p < 0.01 compared with the Glu group. Red ∗∗p < 0.01 compared
with control group. #p < 0.05, #p < 0.001, and red #p < 0.05 compared with its compound alone.
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blocked in Tris buffered saline containing 0.1% Tween-20 (TBST)
and 5% non-fat-dried milk at room temperature for 1 h. Next,
the membranes were incubated with the respective primary
antibodies (anti-CREB 1:500, anti-phospho-CREB 1:500, anti-
BDNF 1:2,000, and CRTC1 1:10,000) overnight at 4◦C. Following
three washes with TBST, the blots were incubated with the
secondary horseradish peroxidase-conjugated antibody (1:6,000)
at room temperature for 1 h, and optical density of protein bands
was determined using an image analysis system (Bio-Imaging
Analyzer, UVP). All the results of western blot consisted of three
independent experiments, and each independent experiment was
performed in triplicate.
Statistical Analysis
Data were presented as mean ± SD. Comparisons were carried
out using one way analysis of variance (ANOVA) followed
by Tukey-Kramer’s test for post hoc analysis. All statistical
analyses were performed using ANOVA by the PRISM software
(GraphPad software, San Diego, CA, USA). P < 0.05 was
considered as statistically significant.
RESULTS
Combination of DISS and TFSA Inhibits
Glu-Induced Decrease in Cell Viability
Figure 1 shows that the EC50 values of DISS and TFSA were
606.4 ± 23.3 µM and 237.8 ± 13.3 µM, respectively. The fixed
concentration of 40 µM TFSA in combination was according to
EC20 of TFSA (40.71 ± 2.47 µM). The EC50 of combination of
DISS and TFSA was 83.86 ± 1.06 µM. CI value of co-treatment
FIGURE 3 | Combination effect of DISS and TFSA on pCREB (phosphor-CREB)/CREB (cAMP response element-binding protein), BDNF, and CRTC1
expressions at the protein level as well as BDNF expression at the mRNA level in SY5Y cell (n = 18). SY5Y cells were treated with 75 µM or 150 µM DISS,
25 µM or 75 µM TFSA, or combination of DISS and TFSA for 24 h. (A,B,C) Combination effect of DISS and TFSA on pCREB/CREB, CRTC1, and BDNF
expressions at the protein level. (D) Combination effect of DISS and TFSA on BDNF expression at the mRNA level. ∗p < 0.05 and ∗∗p < 0.01 compared with the
control group. #p < 0.05 and ##p < 0.01 compared with its compound alone.
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was 0.31, suggesting that combination of DISS and TFSA
possessed a synergistic effect. Next, we investigated whether
the combination of DISS and TFSA could have an additive or
synergistic effect in preventing neuronal damage in SH-SY5Y
cells. In order to lower the possible side effects of the compounds
according to our previous experience, the concentrations of DISS
and TFSA were set to 150/75 µM and 75/50 µM, respectively.
The EC20 of DISS alone was 214.2 ± 1.23 µM. In combination,
we chose 150 or 75 µM DISS that lower than EC20 of DISS and
increased slightly TFSA concentrations based on EC20 of TFSA
alone.
The Effects of MAPK/ERK1/2 and
PI3-K/Akt Inhibitors on the Protective
Effects of DISS and TFSA against
Glu-Induced Decrease in Cell Viability
and Proliferation Rate
Based on this Glu-induced decrease in cell activity, the
neuronal cytotoxicity of Glu could be partially inhibited by the
pretreatment of DISS or TFSA in a dose-dependent manner.
More importantly, the co-treatment of TFSA and DISS at two
testing doses (75 µM + 25 µM and 150 µM + 25 µM)
could produce a significant neuroprotective activity as compared
with individual compounds alone, exhibiting increased cell
viability from 48% to more than 85%. Figures 2A,B shows
that such a protective effect of DISS at 150 and 75 µM
could be blocked by the MAPK/ERK1/2 inhibitor, U0126
(10 µM), but not by the PI3-K inhibitor, LY290042 (20 µM).
In contrast, the LY290042, but not U0126, inhibited the
neuroprotective effect of TFSA. Moreover, the inhibitory effect
of combination of U0126 and LY290042 became even more
obvious, showing reduced cell viability from 85% to less than 60%
(Figure 2C).
Combination Effects of DISS and TFSA
on the Expression of CREB Pathway
Related Key Targets
In order to further understand the mechanism of the
combination effect of DISS and TFSA on the neuroprotection,
we investigated the expressions of CREB, CRTC1, pCREB,
and BDNF. DISS or TFSA alone could induce the protein
expression of pCREB/CREB at both doses, and additive
effect was observed for the combination of DISS and TFSA
(Figure 3A). In addition, TFSA at 25 µM had no effect on the
CRTC1 expression. However, combinations of 25 µM TFSA
and 150 or 75 µM DISS both significantly increased the CRTC1
expression (Figure 3B). Meanwhile, the combinations of DISS
and TFSA at different ratios all significantly enhanced the BDNF
expression at the mRNA and protein levels (Figures 3C,D).
Moreover, BDNF expression at the mRNA level was induced
for more than threefold by combinations of 150 µM DISS
and 25 µM TFSA; 75 µM DISS and 50 µM TFSA; or 75 µM
DISS and 25 µM TFSA compared with compounds alone
(Figure 3D).
The Effects of ERK1/2 and PI-3K
Inhibitors Are Involved in the Regulation
of CRTC1 and BDNF Expressions by
Induced by DISS and TFSA
Considering the various CREB pathways activated by DISS
and TFSA, we assessed the signaling mechanisms involved in
CRTC1 and BDNF regulation using two inhibitors. Figure 4
reveals that treatment of DISS or TFSA increased the expression
of BDNF and CRTC1, but such an increase could be
partially attenuated by either U0126 or LY294002. PI3-K
inhibitor LY294003 showed a similar but weaker inhibitory
effect on DISS-induced CRTC1 expression compared with
FIGURE 4 | Inhibitory effect of ERK1/2 and PI3K on DISS- or
TFSA-induced BDNF and CRTC1 expressions in SY5Y cells (n = 9).
SY5Y cells were pretreated with 10 µM U0126 or 30 µM LY294002 for
30 min, followed by treatment with 150 µM DISS or 50 µM TFSA for 48 h.
(A) Expressions of BDNF and CRTC1 were examined by western blotting.
(B) The expression of BDNF and CRTC1. Data were expressed as
mean ± SD. ∗p < 0.05 and ∗∗p < 0.01 compared with the untreated control
group. #p < 0.05 compared with its compound alone.
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FIGURE 5 | Combination effect of DISS and TFSA on levels of tNOS
and iNOS in SY5Y cells (n = 18). SY5Y cells were exposed to Glu for 24 h,
after which Glu was changed to DISS and TFSA combination medium for
48 h. Levels of tNOS and iNOS were determined by a reagent kit ∗∗p < 0.01
compared with Glu; ∗∗p < 0.01 compared with the control; ∗p < 0.05,
#p < 0.01 compared with its compound alone.
U0126 (Figure 4A). The LY294002 decreased the DISS- or
TFSA-induced BDNF expression by 47 and 25%, respectively.
The ERK1/2 inhibitor U0126 decreased the DISS- or TFSA-
induced BDNF expression by 25 and 21%, respectively.
(Figure 4B). A bigger decrease in DISS- or TFSA-induced BDNF
expression was caused by LY294003 compared with U0126
(Figure 4B).
Combination Effects of DISS and TFSA
on tNOS and iNOS Levels
To further investigate the additive neuroprotection of DISS and
TFSA against the Glu-induced cell injury, we examined the
levels of tNOS and iNOS, which play an important role in cell
apoptosis or neurodegenerative disorders (Chen et al., 2016; Zhu
et al., 2016). Figure 5 shows that Glu significantly increased
the levels of tNOS and iNOS. DISS or TFSA treatment alone
decreased the intracellular level of tNOS by 4–8%, but showed no
effect on iNOS level. However, co-treatment of DISS and TFSA
significantly decreased such an elevation of tNOS and iNOS levels
by 29.3 and 40.5%, respectively. These results suggested that the
combination of DISS and TFSA could more vigorously inhibit the
Glu-induced NO overproduction.
DISCUSSION
The combination strategy offers a series of potential advantages,
including less side effects and a more rapid or effective clinical
response. In the current study, combination of the two active
oligosaccharide esters demonstrated additive neuroprotective
effects against Glu-induced damage. Compared with DISS or
TFSA alone, their combination also significantly increased the
expressions of pCREB, CRTC1, and BDNF.
Several studies have shown that DISS and TFSA play an
antidepressant and neuroprotective role. DISS protects human
neuroblastoma cells (SH-SY5Y) from Glu- or H2O2-induced
damage, and DISS-mediated regulation of BDNF expression
is associated with CREB-mediated transcription of BDNF
and upstream activation of ERK1/2 and CaMKII (Hu et al.,
2014). In our previous study, DISS possesses antidepressant-
like properties, and its underlying mechanism might also
be related to effects on hippocampal neuroplasticity gene
BDNF (Hu et al., 2010). TFSA, with the similar chemical
structure, can also promote the proliferation of C6 glioma
cells, and its mechanism has been related to TrkB/BDNF/ERK
and TrkB/BDNF/PI3-K signaling pathways (Dong et al.,
2014).
FIGURE 6 | The graph of DISS and TFSA synergistically activated the PI-3K/Akt and MAPK/ERK pathways.
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Over the past decades, studies have suggested that
neurotrophins and related signaling cascades are involved in
the pathophysiology of depression. CREB upregulation may
activate downstream targets, such as BDNF, after antidepressant
treatment. In fact, a series of elegant studies have also
shown that PI-3K/Akt and MAPK/Erk pathways, which can
promote neuronal growth and survival, are two key signaling
cascades regulating CREB/BDNF activation (Chen et al., 2007).
Meanwhile, CRTC1, as another essential gene for long-term
synaptic plasticity and synaptic development, also plays an
important role in CREB-dependent gene transcription (Xue et al.,
2015).
In the present study, we, for the first time, showed that
DISS and TFSA possessed additive or synergistic protective
effects on nerve regeneration in vitro. Additive effects were
observed on cell viability, pCREB/CREB, BDNF, CRTC1, tNOS,
and iNOS activities, synergistic effects were observed on BDNF
mRNA. We adopted kinase inhibitors of U0126 and LY294002
to explore the mechanisms. It showed that combination of DISS
and TFSA exerted an additive effect on CREB phosphorylation,
and expressions of CRTC1 and BDNF at the protein level.
Figure 6 illustrates that DISS and TFSA activated the PI-
3K/Akt and MAPK/Erk pathways, leading to stronger activation
of the downstream CREB phosphorylation and simultaneously
increased CRTC1 expression, and both of them were beneficial to
the transcription of BDNF, which could eventually promote the
neuronal survival.
In additional to the role in CREB/BDNF regulation, NO is
an important messenger and effector molecule that possesses
neurotransmitter and neuromodulator functions and participates
in physiological and pathological activities. NO, together with
iNOS and nNOS, is well known to be involved in the pathogenesis
of neurodegenerative disorders (Chen et al., 2007; Di et al., 2010;
Lin et al., 2014). Both N-methyl-D-aspartate receptor activation
and Glu can induce the iNOS expression and NO production,
subsequently leading to excessive damage caused by free radicals
(Akama and Van Eldik, 2000; Di et al., 2010). Our results
indicated that the levels of iNOS and tNOS were significantly
increased in Glu-treated SY5Y cells, while combination of DISS
and TFSA could ameliorate such Glu-induced NO production
and iNOS overdosage, suggesting that the combination effect on
neuroprotection was also involved in regulation of iNOS and
tNOS activities.
CONCLUSION
Combination of DISS and TFSA activated CREB-mediated
MAPK and PI-3K cascades and induced the BDNF expression,
revealing the underlying molecular mechanism of their additive
neuroprotective effects. Our findings suggested the potential of
a novel candidate oligosaccharide ester for the development of
natural supplements against depression. Both DISS and TFSA
are active oligosaccharide ester components found in the root
of Polygala tenuifolia Willd. Our previous study showed that
DISS has anti-depressive activity in vivo (Hu et al., 2010). The
molecular weights of DISS and TFSA are 752 and 682 kDa,
respectively. And both of them are fat-soluble. However, it
remains unclear whether DISS, TFSA or its metabolites could
pass the blood brain barrier. In our future study, we will further
explore their additive or synergistic effects on mental disorder in
animal models and investigate whether they can pass the blood
brain barrier.
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